REQUEST A DEMO
Total
USD $0.00
Search more companies

K G Life Science Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: K G Life Science Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

K G Life Science Private Limited is based in India, with the head office in Ahmedabad. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on August 12, 2010. The latest financial highlights indicate a net sales revenue drop of 5.69% in 2025. Its total assets decreased by 3.62% over the same period. K G Life Science Private Limited’s net profit margin decreased by 0.34% in 2025.

Legal Address
B - 304, Govind Plaza, Kiran Park, Nava Vadaj,
Ahmedabad; Gujarat; Postal Code: 380013

Contact Details: Purchase the K G Life Science Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the K G Life Science Private Limited report to view the information.
Financial Auditors:
Purchase the K G Life Science Private Limited report to view the information.
Incorporation Date:
August 12, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after K G Life Science Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.69%
Total Operating Revenue
-8.76%
Operating Profit
-29.23%
EBITDA
-25.88%
Net Profit/Loss for the Period
-28.9%
Total Assets
-3.62%
Total Equity
29.48%
Operating Profit Margin
-1.33%
Net Profit Margin
-0.34%
Return on Equity (ROE)
-18.7%
Debt / Equity
-232%
Quick Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?